SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000318306-13-000006
Filing Date
2013-04-02
Accepted
2013-04-02 16:15:13
Documents
1
Period of Report
2013-04-02
Effectiveness Date
2013-04-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY proxy040113.htm DEF 14A 453575
  Complete submission text file 0000318306-13-000006.txt   454818
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: DEF 14A | Act: 34 | File No.: 001-15771 | Film No.: 13735532
SIC: 2834 Pharmaceutical Preparations